CRISPR interference-guided balancing of a biosynthetic mevalonate pathway increases terpenoid production.

Methods for simple and efficient regulation of metabolic pathway genes are essential for maximizing product titers and conversion yields, and for minimizing the metabolic burden caused by heterologous expression of multiple genes often in the operon context. Clustered regularly interspaced short palindromic repeats (CRISPR) interference (CRISPRi) is emerging as a promising tool for transcriptional modulation. In this study, we developed a regulatable CRISPRi system for fine-tuning biosynthetic pathways and thus directing carbon flux toward target product synthesis. By exploiting engineered Escherichia coli harboring a biosynthetic mevalonate (MVA) pathway and plant-derived terpenoid synthases, the CRISPRi system successfully modulated the expression of all the MVA pathway genes in the context of operon and blocked the transcription of the acetoacetyl-CoA thiolase enzyme that catalyzes the first step in the MVA pathway. This CRISPRi-guided balancing of expression of MVA pathway genes led to enhanced production of (-)-α-bisabolol (C15) and lycopene (C40) and alleviation of cell growth inhibition that may be caused by expression of multiple enzymes or production of toxic intermediate metabolites in the MVA pathway. Coupling CRISPRi to cell growth by regulating an endogenous essential gene (ispA) increased isoprene (C5) production. The regulatable CRISPRi system proved to be a robust platform for systematic modulation of biosynthetic and endogenous gene expression, and can be used to tune biosynthetic metabolic pathways. Its application can enable the development of microbial 'smart cell' factories that can produce other industrially valuable products in the future.

[1]  Carl W. Gunderson,et al.  Toxic protein expression in Escherichia coli using a rhamnose-based tightly regulated and tunable promoter system. , 2006, BioTechniques.

[2]  Seon-Won Kim,et al.  Selective retinol production by modulating the composition of retinoids from metabolically engineered E. coli , 2015, Biotechnology and bioengineering.

[3]  Max A. Horlbeck,et al.  Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation , 2014, Cell.

[4]  Xianpu Ni,et al.  Assembly of a novel biosynthetic pathway for gentamicin B production in Micromonospora echinospora , 2016, Microbial Cell Factories.

[5]  J. Blatny,et al.  Construction and use of a versatile set of broad-host-range cloning and expression vectors based on the RK2 replicon , 1997, Applied and environmental microbiology.

[6]  J. Keasling,et al.  Metabolic pathway optimization using ribosome binding site variants and combinatorial gene assembly , 2014, Applied Microbiology and Biotechnology.

[7]  Juhyun Kim,et al.  The Standard European Vector Architecture (SEVA): a coherent platform for the analysis and deployment of complex prokaryotic phenotypes , 2012, Nucleic Acids Res..

[8]  S. Atsumi,et al.  Expanding ester biosynthesis in Escherichia coli. , 2014, Nature chemical biology.

[9]  R. Fall,et al.  Enzymatic synthesis of isoprene from dimethylallyl diphosphate in aspen leaf extracts. , 1991, Plant physiology.

[10]  J. Altenbuchner,et al.  Optimization of an E. coli L-rhamnose-inducible expression vector: test of various genetic module combinations , 2008, BMC biotechnology.

[11]  Farren J. Isaacs,et al.  Programming cells by multiplex genome engineering and accelerated evolution , 2009, Nature.

[12]  Jun Li,et al.  Targeted genome modification of crop plants using a CRISPR-Cas system , 2013, Nature Biotechnology.

[13]  D. Ro,et al.  Enantioselective microbial synthesis of the indigenous natural product (-)-α-bisabolol by a sesquiterpene synthase from chamomile (Matricaria recutita). , 2014, The Biochemical journal.

[14]  Brian F. Pfleger,et al.  Application of Functional Genomics to Pathway Optimization for Increased Isoprenoid Production , 2008, Applied and Environmental Microbiology.

[15]  J. Keasling,et al.  Principal component analysis of proteomics (PCAP) as a tool to direct metabolic engineering. , 2015, Metabolic engineering.

[16]  Dae-Hee Lee,et al.  Comparative genomics and experimental evolution of Escherichia coli BL21(DE3) strains reveal the landscape of toxicity escape from membrane protein overproduction , 2015, Scientific Reports.

[17]  Rudolf Jaenisch,et al.  One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering , 2013, Cell.

[18]  F. Studier,et al.  Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. , 1986, Journal of molecular biology.

[19]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[20]  J. Keasling,et al.  Engineering a mevalonate pathway in Escherichia coli for production of terpenoids , 2003, Nature Biotechnology.

[21]  Luke A. Gilbert,et al.  Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression , 2013, Cell.

[22]  J. Keasling,et al.  Engineering dynamic pathway regulation using stress-response promoters , 2013, Nature Biotechnology.

[23]  Christopher A. Voigt,et al.  Multi-input CRISPR/Cas genetic circuits that interface host regulatory networks , 2014, Molecular systems biology.

[24]  Le Cong,et al.  Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.

[25]  Qiong Wu,et al.  Application of CRISPRi for prokaryotic metabolic engineering involving multiple genes, a case study: Controllable P(3HB-co-4HB) biosynthesis. , 2015, Metabolic engineering.

[26]  J. Keasling,et al.  Design of a dynamic sensor-regulator system for production of chemicals and fuels derived from fatty acids , 2012, Nature Biotechnology.

[27]  Gregory Stephanopoulos,et al.  Engineering metabolism and product formation in Corynebacterium glutamicum by coordinated gene overexpression. , 2003, Metabolic Engineering.

[28]  Ron Milo,et al.  Spanning high-dimensional expression space using ribosome-binding site combinatorics , 2013, Nucleic acids research.

[29]  Nam-Hee Kim,et al.  Increase of lycopene production by supplementing auxiliary carbon sources in metabolically engineered Escherichia coli , 2011, Applied Microbiology and Biotechnology.

[30]  T. Hwa,et al.  Interdependence of Cell Growth and Gene Expression: Origins and Consequences , 2010, Science.

[31]  Sang Yup Lee,et al.  Construction and optimization of synthetic pathways in metabolic engineering. , 2010, Current opinion in microbiology.

[32]  T. Kuzuyama.  Mevalonate and Nonmevalonate Pathways for the Biosynthesis of Isoprene Units , 2002, Bioscience, biotechnology, and biochemistry.

[33]  T. Terwilliger,et al.  Engineering and characterization of a superfolder green fluorescent protein , 2006, Nature Biotechnology.

[34]  J. Keasling,et al.  Semi-synthetic artemisinin: a model for the use of synthetic biology in pharmaceutical development , 2014, Nature Reviews Microbiology.

[35]  M. Rodríguez-Concepcíon,et al.  Terpenoid biosynthesis in prokaryotes. , 2015, Advances in biochemical engineering/biotechnology.

[36]  T. Sharkey,et al.  Isoprene synthase expression and protein levels are reduced under elevated O3 but not under elevated CO2 (FACE) in field-grown aspen trees. , 2007, Plant, cell & environment.

[37]  J. Shiloach,et al.  Effect of glucose supply strategy on acetate accumulation, growth, and recombinant protein production by Escherichia coli BL21 (λDE3) and Escherichia coli JM109 , 2000, Biotechnology and bioengineering.

[38]  Junfeng Xue,et al.  Enhancing Isoprene Production by Genetic Modification of the 1-Deoxy-d-Xylulose-5-Phosphate Pathway in Bacillus subtilis , 2011, Applied and Environmental Microbiology.

[39]  Sang Yup Lee,et al.  Comparative multi-omics systems analysis of Escherichia coli strains B and K-12 , 2012, Genome Biology.

[40]  Robert J Linhardt,et al.  CRISPathBrick: Modular Combinatorial Assembly of Type II-A CRISPR Arrays for dCas9-Mediated Multiplex Transcriptional Repression in E. coli. , 2015, ACS synthetic biology.

[41]  Feng Zhang,et al.  CRISPR-assisted editing of bacterial genomes , 2013, Nature Biotechnology.

[42]  Jay D Keasling,et al.  Optimization of the mevalonate-based isoprenoid biosynthetic pathway in Escherichia coli for production of the anti-malarial drug precursor amorpha-4,11-diene. , 2009, Metabolic engineering.

[43]  Jay D Keasling,et al.  Multiplex metabolic pathway engineering using CRISPR/Cas9 in Saccharomyces cerevisiae. , 2015, Metabolic engineering.

[44]  J. Keasling,et al.  Isoprenoid drugs, biofuels, and chemicals--artemisinin, farnesene, and beyond. , 2015, Advances in biochemical engineering/biotechnology.

[45]  J. Doudna,et al.  A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity , 2012, Science.

[46]  Sung-Woo Kim,et al.  High-level production of lycopene in metabolically engineered E. coli , 2009 .

[47]  Yang Liang,et al.  Sequence-specific inhibition of microRNA via CRISPR/CRISPRi system , 2014, Scientific Reports.

[48]  Gregory Stephanopoulos,et al.  Construction of lycopene-overproducing E. coli strains by combining systematic and combinatorial gene knockout targets , 2005, Nature Biotechnology.

[49]  Robert G. Martin,et al.  Detection of low-level promoter activity within open reading frame sequences of Escherichia coli , 2005, Nucleic acids research.

[50]  H. Mori,et al.  Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection , 2006, Molecular systems biology.

[51]  Dong-Myung Kim,et al.  A molecular nanodevice for targeted degradation of mRNA during protein synthesis , 2016, Scientific Reports.

[52]  Jay D Keasling,et al.  Enhanced lycopene production in Escherichia coli engineered to synthesize isopentenyl diphosphate and dimethylallyl diphosphate from mevalonate , 2006, Biotechnology and bioengineering.

[53]  Jay D Keasling,et al.  Metabolic engineering of microbial pathways for advanced biofuels production. , 2011, Current opinion in biotechnology.

[54]  Sang Jun Lee,et al.  Modified Escherichia coli B (BL21), a superior producer of plasmid DNA compared with Escherichia coli K (DH5alpha). , 2008, Biotechnology and bioengineering.

[55]  W. Chung,et al.  Combination of Entner-Doudoroff Pathway with MEP Increases Isoprene Production in Engineered Escherichia coli , 2013, PloS one.

[56]  W. R. Farmer,et al.  Improving lycopene production in Escherichia coli by engineering metabolic control , 2000, Nature Biotechnology.

[57]  Keith E. J. Tyo,et al.  Isoprenoid Pathway Optimization for Taxol Precursor Overproduction in Escherichia coli , 2010, Science.

[58]  Jay D Keasling,et al.  Metabolic engineering of Escherichia coli for limonene and perillyl alcohol production. , 2013, Metabolic engineering.

[59]  Mo Xian,et al.  Biosynthesis of isoprene in Escherichia coli via methylerythritol phosphate (MEP) pathway , 2011, Applied Microbiology and Biotechnology.

[60]  Jay D Keasling,et al.  Combinatorial expression of bacterial whole mevalonate pathway for the production of beta-carotene in E. coli. , 2009, Journal of biotechnology.

[61]  Brian F. Pfleger,et al.  Combinatorial engineering of intergenic regions in operons tunes expression of multiple genes , 2006, Nature Biotechnology.

[62]  J. Keith Joung,et al.  High frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells , 2013, Nature Biotechnology.

[63]  Jingwen Zhou,et al.  Enhancing flavonoid production by systematically tuning the central metabolic pathways based on a CRISPR interference system in Escherichia coli , 2015, Scientific Reports.

[64]  Huimin Zhao,et al.  Customized optimization of metabolic pathways by combinatorial transcriptional engineering , 2012, Nucleic acids research.

[65]  Drena Dobbs,et al.  Standardized reagents and protocols for engineering zinc finger nucleases by modular assembly , 2006, Nature Protocols.

[66]  J. Keasling,et al.  Targeted proteomics for metabolic pathway optimization: application to terpene production. , 2011, Metabolic engineering.

[67]  J. Keasling,et al.  Biosynthesis of plant isoprenoids: perspectives for microbial engineering. , 2009, Annual review of plant biology.

[68]  Kanako Sasaki,et al.  Gene expression and characterization of isoprene synthase from Populus alba , 2005, FEBS letters.

[69]  Jian-Zhong Liu,et al.  Engineering of Escherichia coli for Lycopene Production Through Promoter Engineering. , 2015, Current pharmaceutical biotechnology.

[70]  E. Breitmaier.  Terpenes: Flavors, Fragrances, Pharmaca, Pheromones , 2006 .

[71]  Seon-Won Kim,et al.  Combinatorial engineering of hybrid mevalonate pathways in Escherichiacoli for protoilludene production , 2016, Microbial Cell Factories.

[72]  J. Park,et al.  Metabolic engineering of Escherichia coli using synthetic small regulatory RNAs , 2013, Nature Biotechnology.

[73]  Dae-Hee Lee,et al.  Generating In Vivo Cloning Vectors for Parallel Cloning of Large Gene Clusters by Homologous Recombination , 2013, PloS one.